Page 7 of EBITDA News
Income from operations of the pharma segment was at Rs 741 crore The Board of Jubilant Life Sciences has approved…
Gross profit margin were at 61.1 per cent
Consolidated net profit for Q1 FY 15-16 was Rs 1909.38 million Glenmark Pharmaceuticals announced its results for the first quarter…
In Q1 FY16, pharma revenues were up six per cent YoY at Rs 2,761 million Strides Arcolab posted its financial…
Records Rs 8,922 million EBITDA during Q1 FY2016 Lupin has posted its performance for the first quarter ending June 30,…
For Q4 FY 2014-15, revenues were at Rs 1,154 crores down by six per cent from Rs 1,225 crores Ahmedabad-based…
Acquires Brazil-based Medquímica Indústria Farmacêutica Lupin has posted its performance for the fourth quarter and the financial year ending March…
For Q4FY15 the operating revenue was Rs 133 crores as compared to Rs 107 crores in Q4FY14 SeQuent Scientific announced…
Hindustan Zinc’s revenue at R4,130 crore (+13% y-o-y) was above estimate of Rs3,790 crore, on the back of (a) higher…
Board of Directors has approved sub-division of nominal value of equity shares of the company from Rs 5 each to…
